| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.4 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.4 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |